Close Menu

NEW YORK (GenomeWeb) – A significant majority of Americans are not familiar with personalized medicine, but when told how it could be used to tailor treatments or to assess their disease risk, they believe insurance companies should cover such technologies, according to the results of a survey published today.

When the concept and practice of personalized medicine was explained to those who had not heard about it before — and examples were provided of tests that are already in use — around 65 percent of respondents had a positive reaction to it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.